[Hydroxychloroquine. Cardiology's viewpoint in times of coronavirus pandemic].
Clicks: 280
ID: 106863
2020
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Popular Article
74.7
/100
280 views
224 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Due to the coronavirus disease 2019 (COVID-19) pandemic, a wide number of compounds are under scrutiny regarding their antiviral activity, one of them being hydroxychloroquine. Cardiac aspects of the use of chloroquine and hydroxychloroquine are reviewed in this manuscript. A non-systematic review of the medical literature was performed. Information about their safety and efficacy as antimalarials, antivirals, as well as in the long-term treatment of rheumatic diseases was collected. We found an anti-inflammatory effect with reduction of longterm cardiovascular events, a very infrequent heart disease due to a lysosomal effect of the drug, and at the hemodynamic level hypotension, tachycardia, and QT interval prolongation, exacerbated when combined with azithromycin. However, the rate of adverse cardiac events of hydroxychloroquine (and chloroquine) was low.| Reference Key |
zaidel2020hydroxychloroquinemedicina
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Zaidel, Ezequiel J;Wyss Quintana, Fernando S;Sosa Liprandi, Álvaro;Mendoza, Iván;Márquez, Manlio F;Nuñez, Elaine;Barbosa, Marcia;Baranchuk, Adrián; |
| Journal | medicina |
| Year | 2020 |
| DOI | DOI not found |
| URL | URL not found |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.